Search

Your search keyword '"Ulrik S. Justesen"' showing total 3 results
Start Over Author "Ulrik S. Justesen" Topic sars-cov-2
3 results on '"Ulrik S. Justesen"'

1. Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections

Author

Rune M. Pedersen, Line L. Bang, Ditte S. Tornby, Lone W. Madsen, Dorte K. Holm, Thomas V. Sydenham, Isik S. Johansen, Thøger G. Jensen, Ulrik S. Justesen, and Thomas E. Andersen

Subjects
COVID-19, respiratory infections, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, SARS, coronavirus disease, Medicine, Infectious and parasitic diseases, RC109-216
Abstract

Worldwide, millions of persons have received multiple COVID-19 vaccinations and subsequently recovered from SARS-CoV-2 Omicron breakthrough infections. In 2 small, matched cohorts (n = 12, n = 24) in Denmark, we found Omicron BA.1/BA.2 breakthrough infection after 3-dose BNT162b2 vaccination provided improved Omicron BA.5 neutralization over 3-dose vaccination alone.

Published
2022
Full Text
View/download PDF

2. Neutralization of SARS-CoV-2 Omicron and Delta Variants in Relation to Vaccine-Induced Antibody Levels in Kidney Transplant Recipients and Healthy Controls

Author

Rune M. Pedersen, Line L. Bang, Ditte S. Tornby, Helene Kierkegaard, Anna C. Nilsson, Isik S. Johansen, Thomas V. Sydenham, Thøger G. Jensen, Ulrik S. Justesen, Claus Bistrup, and Thomas E. Andersen

Subjects
COVID-19, Delta, kidney transplant recipients, Omicron, PRNT, SARS-CoV-2, Microbiology, QR1-502
Published
2022
Full Text
View/download PDF

3. Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination

Author

Rune M. Pedersen, Line L. Bang, Lone W. Madsen, Thomas V. Sydenham, Isik S. Johansen, Thøger G. Jensen, Ulrik S. Justesen, and Thomas E. Andersen

Subjects
COVID-19, respiratory infections, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, SARS, coronavirus disease, Medicine, Infectious and parasitic diseases, RC109-216
Abstract

The SARS-CoV-2 Omicron variant BA.2 sublineage is rapidly replacing earlier Omicron lineages, suggesting BA.2 has increased vaccine evasion properties. We measured neutralization titers of authentic BA.1 and BA.2 isolates in serum samples from persons who received the BNT162b2 booster vaccine. All samples neutralized BA.1 and BA.2 at equal median values.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results